Elekta’s Leksell Gamma Knife Icon radiosurgery system has received 510(k) clearance from the US Food and Drug Administration, enabling US healthcare providers to offer this advanced technology to their patients. With stereotactic imaging, online Adaptive DoseControl, ultra-precise dose delivery and the availability of frameless treatments, Icon is capable of treating virtually any target in the brain, regardless of type, location or volume.
A study released at the Society of NeuroInterventional Surgery 12th Annual Meeting (27–30 July, San Francisco, USA), indicates that strict adherence to two commonly-used tools to weigh the risk of treating unruptured aneurysms may not prevent the majority of morbidity-mortality outcomes associated with ruptured intracranial aneurysms. Thus, the International Study of Unruptured Intracranial Aneurysms (ISUIA) criteria and the PHASES score require additional research to determine their effectiveness.
In the last decade, intra-arterial stroke therapy (in which thrombolytic agents and devices are passed through the arteries directly to the clot site) has gained notable momentum as an effective and safe treatment option for patients. Two new studies released at the Society of NeuroInterventional Surgery 12th Annual Meeting (27–30 July, San Francisco, USA) further reinforce the value and progress of intra-arterial treatment and conclude that the new devices that facilitate this approach are reducing treatment times, improving outcomes and decreasing mortality rates.
Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, has introduced a new platform of embolic coils for the treatment of brain aneurysms, supported by an enhanced detachment system designed to improve microcatheter stability and provide an optimised detachment zone for coils. The announcement was made at the Society of NeuroInterventional Surgery 12th Annual Meeting (SNIS; 27–30 July, San Francisco, USA).
Use of mechanical thrombectomy on qualifying stroke patients could result in major savings to the healthcare economy in the United Kingdom and other western countries with a similar healthcare structure, according to a new study presented at the Society of NeuroInterventional Surgery 12th Annual Meeting in San Francisco, USA.
Two new studies presented at the Society of NeuroInterventional Surgery 12th Annual Meeting in San Francisco, USA, report that Mobile Stroke Treatment Units (MSTUs) can significantly reduce the time it takes to diagnose and treat patients for stroke, greatly improving survival rates and enhancing a patient’s chance of recovery.
Despite efforts to close the time gap between symptom onset and stroke treatment – including improvements in public education, 911 dispatch operations, pre-hospital detection and triage, hospital stroke system development, and stroke unit management – a new study presented at the Society of NeuroInterventional Surgery (SNIS) 12th Annual Meeting suggests that delays in emergency transport are still prevalent and that improvements are needed to ensure patients can be treated within the optimal time window.
Penumbra has announced that the results of the European multicentre study of the company’s ACE64 thrombectomy system were presented in the Abstract Presentations Session at the Society of NeuroInterventional Surgery (SNIS) 12th Annual Meeting in San Francisco, USA. ACE64 is the most recent innovation in mechanical thrombectomy technology since the landmark MR CLEAN and subsequent confirmatory trials demonstrated the efficacy of endovascular treatment for patients with acute ischaemic stroke.
A new blood test could help emergency room doctors quickly diagnose traumatic brain injury and determine its severity. The findings, published in the Journal of Neurotrauma, could help identify patients who might benefit from extra therapy or experimental treatments.
New research suggests older people who experience migraines may have an increased risk of stroke, but only if they are smokers. The study is published by Neurology, the medical journal of the American Academy of Neurology.
Hospitals often overestimate their performance in providing fast delivery of anti-clotting medication to stroke patients, according to new research in the Journal of the American Heart Association.
A study published in the journal Stroke has added to the evidence supporting the use of local anaesthesia when possible during endovascular treatment of acute ischaemic stroke. The question of improved outcome associated with the use of local anaesthesia has been one increasingly being raised since the release of overwhelmingly positive results in favour of endovascular treatment of acute stroke in five stroke trials around the world.
Sequent Medical has been granted a new patent from the US Patent and Trademark Office covering many versions of Sequent’s Web aneurysm embolisation system.
Three medical centres in the UK and Germany have ordered and are now planning upgrades to Elekta’s latest generation stereotactic radiosurgery system for the brain, Leksell Gamma Knife Icon, to provide advanced brain radiosurgery treatments for their patients.
Uric acid—a chemical that at high levels can lead to serious illness—may lessen women’s disability after stroke, according to new research in the American Heart Association’s journal Stroke.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos